Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
27,149,143
-
Share change
-
-529,365
-
Total reported value
-
$284,285,000
-
Price per share
-
$10.50
-
Number of holders
-
77
-
Value change
-
-$5,516,082
-
Number of buys
-
34
-
Number of sells
-
27
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q3 2017
As of 30 Sep 2017,
AVADEL PHARMACEUTICALS - COM (AVDL) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,149,143 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT CO, Broadfin Capital, LLC, JANUS HENDERSON GROUP PLC, ARMISTICE CAPITAL, LLC, ACADIAN ASSET MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, MORGAN STANLEY, DEUTSCHE BANK AG\, Stonepine Capital Management, LLC, and BROWN CAPITAL MANAGEMENT LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.